Li Song
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Li Song has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Bo Jia
College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
1 shared publicationHeng-Chang Hu
College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
1 shared publication- Jinlin Guo
Chengdu University of Traditional Chinese Medicine
1 shared publication Jun-Yu Liu
College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
1 shared publicationPei-Yu Xiong
College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
1 shared publication- Qianhua Yan
Department of Endocrinology, Jiangsu Hospital of Chinese Medicine, Nanjing, Jiangsu 210029, P.R. China
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by Elsevier in SSRN Electronic Journal
LAMA5-Mediated Activation of Notch Signaling Drives Epithelial–Mesenchymal Transition in Diabetic Kidney Disease: Therapeutic Intervention by Astragaloside IV
To investigate whether astragaloside IV (AS IV) reverses epithelial–mesenchymal transition (EMT) in renal tubular epithelial cells in diabetic kidney disease (DKD) by regulating LAMA5 to inhibit Notch signaling.A DKD model was established using db/db mice. Differentially expressed genes were screened by bulk RNA-seq combined with DESeq2, followed by GO-BP enrichment analysis. GEO datasets were subgrouped by median LAMA5 expression, and GSEA was used to analyze the relationship between LAMA5 and Notch/EMT pathways. In high glucose (HG)-induced HK-2 cells, LAMA5 and Notch1 were overexpressed or silenced, and Notch pathway molecules (Notch1, Snail, Slug, Twist) and EMT markers (E-cadherin, N-cadherin, Fibronectin, Vimentin) were detected. Forward and reverse gene intervention experiments were performed to verify the target of AS IV. AS IV reduced BUN, CRE, MAU, and UP levels and alleviated renal tubular injury and interstitial fibrosis in DKD mice. LAMA5 was upregulated in DKD and decreased after AS IV intervention, with differentially expressed genes enriched in the Notch pathway. GEO analysis showed EMT was significantly upregulated in DKD samples with high LAMA5 expression. In HK-2 cells, LAMA5 overexpression upregulated Notch1, NICD1, Snail, Slug, and Twist, while silencing LAMA5 inhibited them. AS IV downregulated Notch molecules and reversed EMT in vivo and in vitro. Forward and reverse intervention confirmed that AS IV's anti-EMT effect depends on LAMA5 downregulation. AS IV reverses EMT in DKD renal tubular epithelial cells by downregulating LAMA5 to inhibit abnormal Notch activation. This study is the first to reveal the function of the "LAMA5–Notch–EMT" axis in DKD tubular injury.
- 15 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessLAMA5-Mediated Activation of Notch Signaling Drives Epithelial–Mesenchymal Transition in Diabetic Kidney Disease: Therapeutic Intervention by Astragaloside IV
To investigate whether astragaloside IV (AS IV) reverses epithelial–mesenchymal transition (EMT) in renal tubular epithelial cells in diabetic kidney disease (DKD) by regulating LAMA5 to inhibit Notch signaling.A DKD model was established using db/db mice. Differentially expressed genes were screened by bulk RNA-seq combined with DESeq2, followed by GO-BP enrichment analysis. GEO datasets were subgrouped by median LAMA5 expression, and GSEA was used to analyze the relationship between LAMA5 and Notch/EMT pathways. In high glucose (HG)-induced HK-2 cells, LAMA5 and Notch1 were overexpressed or silenced, and Notch pathway molecules (Notch1, Snail, Slug, Twist) and EMT markers (E-cadherin, N-cadherin, Fibronectin, Vimentin) were detected. Forward and reverse gene intervention experiments were performed to verify the target of AS IV. AS IV reduced BUN, CRE, MAU, and UP levels and alleviated renal tubular injury and interstitial fibrosis in DKD mice. LAMA5 was upregulated in DKD and decreased after AS IV intervention, with differentially expressed genes enriched in the Notch pathway. GEO analysis showed EMT was significantly upregulated in DKD samples with high LAMA5 expression. In HK-2 cells, LAMA5 overexpression upregulated Notch1, NICD1, Snail, Slug, and Twist, while silencing LAMA5 inhibited them. AS IV downregulated Notch molecules and reversed EMT in vivo and in vitro. Forward and reverse intervention confirmed that AS IV's anti-EMT effect depends on LAMA5 downregulation. AS IV reverses EMT in DKD renal tubular epithelial cells by downregulating LAMA5 to inhibit abnormal Notch activation. This study is the first to reveal the function of the "LAMA5–Notch–EMT" axis in DKD tubular injury.
- Top Cited PapersOpen Access
- 28 December 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 170, 116039
Natural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems
- 28 December 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 170, 116039
Top Cited PapersOpen AccessNatural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems